BLCO 241220 30.00C (BLCO241220C30000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BLCO241220C30000

Watchlist

0.25
0.000.00%

15min DelayClose Dec 11 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Bausch Health Says Board Authorized Management To Explore Potential Sale Of Subsidiary Bausch + Lomb; Says Process Is Ongoing. No Decision Has Been Reached
Benzinga8minutes ago
Bausch + Lomb Responds to Rumors of a Potential Sale
Businesswire23minutes ago
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $23
Moomoo News52minutes ago · Ratings
Top Gap Ups and Downs on Wednesday: MLI, MSTR, GSK and More
Moomoo News18:00 ET · Markets
Sector Update: Financial Stocks Advance Late Afternoon
MT Newswires15:36 ET
Sector Update: Financial
MT Newswires13:28 ET

Comments

Meltyy

Feb 21 21:25

Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?

In today’s market, one of the biggest winners generating outsized interest is $Emergent BioSolutions (EBS.US)$ . This mid-cap biotech company remains a unique turnaround story for investors, and many appear to be placing their bets on this company to come out of the pile as a key winner. Indeed, EBS stock has surged over 70% higher on some intriguing news this afternoon.
The company’s turnaround efforts appear to be receiving a jolt today, wit...

Mett

Sep 14, 2022 09:29

$Bausch + Lomb Corp. (BLCO.US)$
EP 17.19
SL 16.49

Analysts Notebook

Sep 12, 2022 08:36

Columns US Top Rating Updates on 9/12: ADBE, OXY, RBLX, UNP and More

Upgrades
• $Argo Group International (ARGO.US)$ : Compass Point Upgrades to Buy from Neutral - PT $28.50
• $Apache (APA.US)$ : Citigroup Upgrades to Buy from Neutral - PT $58 (from $40)
• $Canadian National Railway (CNI.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $135 (from $128)
• $Canadian Pacific Railway (CP.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $87 (from $85)
• $Carpenter Technology (CRS.US)$ : Cowen Upgra...

Analysts Notebook

Sep 9, 2022 07:00

Columns US Top Rating Updates on 9/9: MMM, REGN, ENPH, PSNY and More

Analysts Notebook

Jul 26, 2022 06:32

Columns Top upgrades and downgrades on 7/26: UBS, ROKU, PARA, CHWY and more

Upgrades
• $Zymergen (ZY.US)$ : JPMorgan Upgrades to Neutral from Underweight
Downgrades
• $Chewy (CHWY.US)$: Wedbush Downgrades to Neutral from Outperform - PT $44 (from $35)
• $Paramount Global-B (PARA.US)$: Goldman Sachs Downgrades to Sell from Buy - PT $20 (from $37)
• $Roku Inc (ROKU.US)$: Wolfe Research Downgrades to Underperform from Peerperform - PT $77
• $UBS Group (UBS.US)$: BofA Securities Downgrades to Neutral from Buy - P...